(Q59573812)

1

0 references

Rogerio C de Castro

2

0 references

Marcos Toyama

3

0 references

Jose R Giglio

4

0 references

Sergio Marangoni

5

0 references

Gilberto De Nucci

6

0 references

Edson Antunes

Phospholipase A2 myotoxins from Bothrops snake venoms

7

0 references

language of work or name

English

0 references

publication date

May 2000

0 references

published in

Biochemical Pharmacology

0 references

volume

59

0 references

issue

10

0 references

page(s)

1289-1294

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

A study of phospholipase A2-induced oedema in rat paw.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Sequence analysis of Lys49 phospholipase A2 myotoxins: a highly conserved class of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Antagonism of the myotoxic effects of Bothrops jararacussu venom and bothropstoxin by polyanions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Neutralization of the cytolytic and myotoxic activities of phospholipases A 2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

A heparin-sensitive phospholipase A2 and prostaglandin endoperoxide synthase-2 are functionally linked in the delayed phase of prostaglandin D2 generation in mouse bone marrow-derived mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity of bothropstoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Mast cell degranulation induced by two phospholipase A2 homologues: Dissociation between enzymatic and biological activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Fractionation of Bothrops pirajai snake venom: isolation and characterization of piratoxin-I, a new myotoxic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Comparison with corticotropin-(1–24)-peptide, polyarginine, polylysine and antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

A model to explain the pharmacological effects of snake venom phospholipases A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Oedema formation and degranulation of mast cells by phospholipase A2 purified from porcine pancreas and snake venoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Chemical modification of histidine and lysine residues of myotoxic phospholipases A2 isolated from Bothrops asper and Bothrops godmani snake venoms: effects on enzymatic and pharmacological properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Heparin prevents the binding of phospholipase A2 to phospholipid micelles: importance of the amino-terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Inhibition of human secretory class II phospholipase A2 by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Type II secretory phospholipase A2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Some studies on the release of histamine from mast cells stimulated with polylysine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Pharmacological characterization of polycation-induced rat hind-paw oedema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

In vitro studies of the interaction between heparin and eosinophil cationic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Inflammatory responses induced by poly-l-arginine in rat lungsin vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Histidine at the active site of phospholipase A2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

p-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Crystal structure of bovine pancreatic phospholipase A2 covalently inhibited by p-bromo-phenacyl-bromide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Structure of a snake venom phospholipase A2 modified by p-bromo-phenacyl-bromide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Nonspecific inhibition of enzymes by p-bromophenacyl bromide. Inhibition of human platelet phospholipase C and modification of sulfhydryl groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3

Receptors for a growing family of secreted phospholipases A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900248-3